What the case reports tell us collectively Several patterns emerge across all published cases
found that GLP-1R activation reduced tumor growth and metastatic potential by inhibiting ERK1/2 and AKT phosphorylation, lowering MMP-2 and MMP-9 expression, and increasing E-cadherin
As a triple agonist activating GLP-1, GIP, and glucagon receptors, it provides the most comprehensive receptor coverage available
Urine and faeces were shown to be important routes of excretion, with urine as the primary route in both humans and animals[1]
This does not necessarily make the medication toxic, but it does make it less effective
It still does what it always doesaffects your nervous system, shifts blood sugar, irritates your stomach a bit